Skin and cosmetic evidence
If GHK-Cu has a flagship use backed by real human data, it is topical skin care.
The largest body of human evidence GHK-Cu has
If GHK-Cu has a flagship use backed by real human data, it is topical skin care. One randomized double-blind split-face trial reports measurable reductions in wrinkle volume and depth from a copper-peptide serum, and a small pilot reports raised procollagen synthesis. The firmness and skin-density results that reviews repeat reach this course only through other papers’ accounts of studies it cannot read, so this unit quotes no number from them. Skin is where most of the readable human studies sit, and the wounds unit adds a randomized diabetic-ulcer trial.
This unit walks the best skin trials, the fibroblast mechanism that explains them, and a fair comparison with retinol. It is the high-water mark of the evidence, and it is still cosmetic-grade, which is an important boundary to keep.
Key terms
The wrinkle trial numbers
The most-cited cosmetic wrinkle result reports that a GHK-Cu serum in a nano-lipid carrier reduced wrinkle volume and depth versus control, and beat a peptide comparator on one endpoint, in 40 female volunteers aged 40 to 65 over 8 weeks. It was run split-face: each participant applied the serum to the right side of the face and a control to the left, so each woman acted as her own control. The two controls were split between two randomized groups, one comparing against the vehicle and one against the peptide comparator, so each headline comparison rests on about half of the 40 women, and the results table covers 39. It is worth knowing and not worth leaning on, for reasons this page states rather than implies: each comparison is small, the trial was run at a contract cosmetic-testing institute, and it was industry-funded.
This is real, controlled human evidence, which is rare for any peptide. The honest framing is that it is a small, short, cosmetic-endpoint trial of one formulation, strong enough to take seriously and not strong enough to generalize to every cream or claim.
AdvancedThe commercial relationships on this trial, stated in full
This course applies a conflict-of-interest lens to the review literature, so it applies the same lens here, to its own strongest positive skin result. The raw GHK-Cu was purchased from a named supplier. The trial was conducted at Dermatest GmbH, described in the paper as a cosmetic research institute, and one of the authors is affiliated to that institute. And the study names its sponsor: it was funded by Snowberry New Zealand Ltd in collaboration with Callaghan Innovation, with the paper adding that Snowberry had no involvement in the collection, analysis or interpretation of data, the decision to submit, or the writing. Those are fetched facts, recorded here without any inference about intent, exactly as the Pickart affiliations are recorded elsewhere in this course. Add the ordinary limits, a single 40-person eight-week trial of one formulation, and you have a result to take seriously and not to lean on.